Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometry.
about
Unique domain appended to vertebrate tRNA synthetase is essential for vascular developmentRole of ELA region in auto-activation of mutant KIT receptor: a molecular dynamics simulation insightHotspot mutations in KIT receptor differentially modulate its allosterically coupled conformational dynamics: impact on activation and drug sensitivityActivation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases.Differential hydrogen/deuterium exchange mass spectrometry analysis of protein-ligand interactionsEpitope mapping of a 95 kDa antigen in complex with antibody by solution-phase amide backbone hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry.Nucleotide-induced conformational changes of tetradecameric GroEL mapped by H/D exchange monitored by FT-ICR mass spectrometryPlatelet-derived growth factor/vascular endothelial growth factor receptor inactivation by sunitinib results in Tsc1/Tsc2-dependent inhibition of TORC1Hydrogen exchange mass spectrometry of functional membrane-bound chemotaxis receptor complexesMolecular mechanisms of drug resistance in tyrosine kinases cAbl and cKit.HDX-MS takes centre stage at unravelling kinase dynamics.Protein conformation ensembles monitored by HDX reveal a structural rationale for abscisic acid signaling protein affinities and activities.
P2860
Q27677398-D9B61287-1A65-4477-AC81-C8DB11DF1C39Q28293108-427C824B-61F7-40D4-B56B-B00795950650Q28541374-7A322C8D-13CF-4262-849E-53DC8F422D15Q33874259-AE3BB3AF-D863-4E1A-B9D4-48A47405FB3BQ35040616-659C64BE-5F97-42BE-BEA9-877BE06C823FQ35214448-05F4A7EC-355E-42A8-878E-DE79B64C82E9Q36605501-9E7DE4EB-E4D4-408E-8267-728881017ECAQ37264981-3D53B2F2-6A92-44D6-A979-3D156443D703Q37580824-0DBCFD89-46D1-4C6A-BE70-CA857C00DD8CQ37871600-037E6676-7498-41C5-8550-768E95F73B0BQ38180771-3A8FDD2F-21E8-46C7-BD6A-5AC7D7D55946Q38455943-87956183-A80F-4975-92CC-3BE02571E2C1
P2860
Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometry.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Drug binding and resistance me ...... hange FTICR mass spectrometry.
@ast
Drug binding and resistance me ...... hange FTICR mass spectrometry.
@en
type
label
Drug binding and resistance me ...... hange FTICR mass spectrometry.
@ast
Drug binding and resistance me ...... hange FTICR mass spectrometry.
@en
prefLabel
Drug binding and resistance me ...... hange FTICR mass spectrometry.
@ast
Drug binding and resistance me ...... hange FTICR mass spectrometry.
@en
P2093
P2860
P356
P1433
P1476
Drug binding and resistance me ...... change FTICR mass spectrometry
@en
P2093
Alan G Marshall
Elizabeth A Lunney
Hui-Min Zhang
Ketan S Gajiwala
Michael J Greig
Wade Diehl
P2860
P304
P356
10.1002/PRO.347
P50
P577
2010-04-01T00:00:00Z